Anti-HELZ monoclonal antibody

Pre-made anti-HELZ monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to HELZ/HELZ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0958-Ab-1/ GM-Tg-hg-IP0958-Ab-2Anti-Human HELZ monoclonal antibodyHuman
GM-Tg-rg-IP0958-Ab-1/ GM-Tg-rg-IP0958-Ab-2Anti-Rat HELZ monoclonal antibodyRat
GM-Tg-mg-IP0958-Ab-1/ GM-Tg-mg-IP0958-Ab-2Anti-Mouse HELZ monoclonal antibodyMouse
GM-Tg-cynog-IP0958-Ab-1/ GM-Tg-cynog-IP0958-Ab-2Anti-Cynomolgus/ Rhesus macaque HELZ monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0958-Ab-1/ GM-Tg-felg-IP0958-Ab-2Anti-Feline HELZ monoclonal antibodyFeline
GM-Tg-cang-IP0958-Ab-1/ GM-Tg-cang-IP0958-Ab-2Anti-Canine HELZ monoclonal antibodyCanine
GM-Tg-bovg-IP0958-Ab-1/ GM-Tg-bovg-IP0958-Ab-2Anti-Bovine HELZ monoclonal antibodyBovine
GM-Tg-equg-IP0958-Ab-1/ GM-Tg-equg-IP0958-Ab-2Anti-Equine HELZ monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0958-Ab-1/ GM-Tg-hg-IP0958-Ab-2; GM-Tg-rg-IP0958-Ab-1/ GM-Tg-rg-IP0958-Ab-2;
GM-Tg-mg-IP0958-Ab-1/ GM-Tg-mg-IP0958-Ab-2; GM-Tg-cynog-IP0958-Ab-1/ GM-Tg-cynog-IP0958-Ab-2;
GM-Tg-felg-IP0958-Ab-1/ GM-Tg-felg-IP0958-Ab-2; GM-Tg-cang-IP0958-Ab-1/ GM-Tg-cang-IP0958-Ab-2;
GM-Tg-bovg-IP0958-Ab-1/ GM-Tg-bovg-IP0958-Ab-2; GM-Tg-equg-IP0958-Ab-1/ GM-Tg-equg-IP0958-Ab-2
Products NameAnti-HELZ monoclonal antibody
Formatmab
Target NameHELZ
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-HELZ monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0958-Ag-1Recombinant multi-species HELZ/ DHRC/ DRHC protein


    Target information

    Target IDGM-IP0958
    Target NameHELZ
    Gene ID9931,78455,287773,718729,490907,101101269,539501,100053580
    Gene Symbol and Synonyms3110078M01Rik,9430093I07Rik,9630002H22Rik,DHRC,DRHC,HELZ,HUMORF5
    Uniprot AccessionP42694
    Uniprot Entry NameHELZ_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000198265
    Target ClassificationN/A

    The target: HELZ, gene name: HELZ, also named as DHRC, DRHC, HUMORF5. HELZ is a member of the superfamily I class of RNA helicases. RNA helicases alter the conformation of RNA by unwinding double-stranded regions, thereby altering the biologic activity of the RNA molecule and regulating access to other proteins (Wagner et al., 1999 [PubMed 10471385]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.